| ABPP | activity-based protein profiling |
| AI | artificial intelligence |
| ANX | Annexin |
| ATP | adenosine triphosphate |
| BBB | blood–brain barrier |
| BET | Brunauer–Emmett–Teller |
| BSA | bovine serum albumin |
| CRT | calreticulin |
| DC | dendritic cell |
| DLAT | dihydrolipoamide S-acetyltransferase |
| ELISA | enzyme-linked immunosorbent assay |
| EMA | European Medicines Agency |
| EpCAM | epithelial cell adhesion molecule |
| EPR | enhanced permeability and retention |
| FDA | Food and Drug Administration |
| FLS | fibroblast-like synoviocyte |
| GLUT | glucose transporter |
| GMP | Good Manufacturing Practice |
| GSH | glutathione |
| HA | hyaluronic acid |
| HMGB | high mobility group box |
| HSA | human serum albumin |
| ICD | immunogenic cell death |
| INE | inflammatory neutrophil |
| i.t. | intratumorally |
| IVIVC | in vitro-in vivo correlation |
| LMWH | low molecular weight heparin |
| LPS | lipopolysaccharide |
| MOF | metal–organic framework |
| NET | neutrophil extracellular trap |
| NF-κB | nuclear factor kappa-B |
| PAGE | polyacrylamide gel electrophoresis |
| PAMAM | poly(amidoamine) |
| PAT | process analytical technology |
| PCL | poly(ε-caprolactone) |
| PD | pharmacodynamics |
| PDA | poly(dopamine) |
| PD-L1 | programmed cell death ligand 1 |
| PEG | poly(ethylene glycol) |
| PEI | poly(ethylene imine) |
| PK | pharmacokinetics |
| PLGA | poly(lactic-co-glycolic acid) |
| PPS | poly(propylene sulfide) |
| PSN | P-selectin targeting peptide |
| PUMA | p53 upregulated modulator of apoptosis |
| QbD | quality-by-design |
| QC | quality control |
| ROS | reactive oxygen species |
| SDS | sodium dodecyl sulfate |
| siPD-L1 | siRNA targeting programmed death ligand 1 |
| tFNA | tetrahedral framework nucleic acid |
| TKPF | thioketal-crosslinked fluorinated polyethyleneimine |
| ZIF | zeolitic imidazolate framework |